Managing Neovascular Age-Related Macular Degeneration in Clinical Practice: Systematic Review, Meta-Analysis, and Meta-Regression

被引:20
作者
Veritti, Daniele [1 ]
Sarao, Valentina [1 ,2 ]
Soppelsa, Valentina [1 ]
Danese, Carla [1 ]
Chhablani, Jay [3 ]
Lanzetta, Paolo [1 ,2 ]
机构
[1] Univ Udine, Dept Med Ophthalmol, I-33100 Udine, Italy
[2] Ist Europeo Microchirurg Oculare IEMO, I-33100 Udine, Italy
[3] Univ Pittsburgh, Sch Med, Med Retina & Vitreoretinal Surg, Pittsburgh, PA 15261 USA
关键词
aflibercept; age-related macular degeneration; anti-VEGF; bevacizumab; brolucizumab; meta-analysis; meta-regression; ranibizumab; TREAT-AND-EXTEND; ENDOTHELIAL GROWTH-FACTOR; OPTICAL COHERENCE TOMOGRAPHY; VISUAL-ACUITY OUTCOMES; PIGMENT EPITHELIAL DETACHMENTS; PRO-RE-NATA; INTRAVITREAL RANIBIZUMAB TREATMENT; TREATMENT-NAIVE PATIENTS; SUBFOVEAL CHOROIDAL NEOVASCULARIZATION; FLUENCE PHOTODYNAMIC THERAPY;
D O I
10.3390/jcm11020325
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The use of anti-vascular endothelial growth factor (VEGF) agents has profoundly changed the prognosis of neovascular age-related macular degeneration (nAMD). As clinical experiences have accumulated, it has become mandatory to summarize data to give information that can be useful in everyday practice. We conducted a systematic review to identify randomized controlled trials (RCTs) and observational studies that reported 12-month changes in best-corrected visual acuity (BCVA) in patients with nAMD on anti-VEGF monotherapy. Data were analyzed in a random-effects meta-analysis with BCVA change as the primary outcome. Meta-regression was conducted to evaluate the impact of multiple covariates. Four hundred and twelve heterogeneous study populations (109,666 eyes) were included. Anti-VEGFs induced an overall improvement of +5.37 ETDRS letters at 12 months. Meta-regression showed that mean BCVA change was statistically greater for RCTs (p = 0.0032) in comparison with observational studies. Populations following a proactive regimen had better outcomes than those following a reactive treatment regimen. Mean BCVA change was greater in younger populations, with lower baseline BCVA and treated with a higher number of injections (p < 0.001). Our results confirm that anti-VEGFs may produce a significant functional improvement at 12 months in patients with nAMD.
引用
收藏
页数:22
相关论文
共 282 条
  • [41] Ten-year outcomes of antivascular endothelial growth factor therapy in neovascular age-related macular degeneration
    Chandra, Shruti
    Arpa, Cristina
    Menon, Deepthy
    Khalid, Hagar
    Hamilton, Robin
    Nicholson, Luke
    Pal, Bishwanath
    Fasolo, Sandro
    Hykin, Philip
    Keane, Pearse A.
    Sivaprasad, Sobha
    [J]. EYE, 2020, 34 (10) : 1888 - 1896
  • [42] Intravitreal aflibercept for neovascular age-related macular degeneration in patients aged 90 years or older: 2-year visual acuity outcomes
    Chatziralli, Irini
    Regan, Shane O.
    Mohamed, Ryian
    Talks, James
    Sivaprasad, Sobha
    [J]. EYE, 2018, 32 (09) : 1523 - 1529
  • [43] Bilateral visual outcomes and service utilization of patients treated for 3 years with ranibizumab for neovascular age-related macular degeneration
    Chavan, Randhir
    Panneerselvam, Swati
    Adhana, Parul
    Narendran, Nirodhini
    Yang, Yit
    [J]. CLINICAL OPHTHALMOLOGY, 2014, 8 : 717 - 723
  • [44] TYPE 1 VERSUS TYPE 3 NEOVASCULARIZATION IN PIGMENT EPITHELIAL DETACHMENTS ASSOCIATED WITH AGE-RELATED MACULAR DEGENERATION AFTER ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY A Prospective Study
    Chen, Xuejing
    Al-Sheikh, Mayss
    Chan, Clement K.
    Hariri, Amir H.
    Abraham, Prema
    Lalezary, Maziar
    Lin, Steven G.
    Sadda, Srinivas
    Sarraf, David
    [J]. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2016, 36 (12): : S50 - S64
  • [45] Bilateral Neovascular Age-Related Macular Degeneration: Comparisons between First and Second Eyes
    Chew, Jamie K.
    Zhu, Meidong
    Broadhead, Geoffrey K.
    Luo, Kehui
    Hong, Thomas
    Chang, Andrew A.
    [J]. OPHTHALMOLOGICA, 2017, 238 (1-2) : 23 - 30
  • [46] FUNDUS AUTOFLUORESCENCE NOT PREDICTIVE OF TREATMENT RESPONSE TO INTRAVITREAL BEVACIZUMAB IN EXUDATIVE AGE-RELATED MACULAR DEGENERATION
    Chhablani, Jay
    Kozak, Igor R.
    Mojana, Francesca
    Cheng, Lingyun
    Morrison, Victoria L.
    Wang, Haiyan
    Kim, Jae Suk
    Dustin, Laurie
    Azen, Stanley
    Freeman, William R.
    [J]. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2012, 32 (08): : 1465 - 1470
  • [47] Chiam PJ, 2016, INT J OPHTHALMOL-CHI, V9, P551, DOI 10.18240/ijo.2016.04.12
  • [48] Effect of Epiretinal Membranes on Antivascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular Degeneration
    Cho, Han Joo
    Kim, Jae Min
    Kim, Hyoung Seok
    Lee, Dong Won
    Kim, Chul Gu
    Kim, Jong Woo
    [J]. JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2017, 33 (06) : 452 - 458
  • [49] RETINAL PIGMENT EPITHELIAL TEAR AFTER INTRAVITREAL RANIBIZUMAB TREATMENT FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
    Cho, Han Joo
    Kim, Hyoung Seok
    Yoo, Seul Gi
    Han, Jung Il
    Lew, Young Ju
    Cho, Sung Won
    Lee, Tae Gon
    Kim, Jong Woo
    [J]. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2016, 36 (10): : 1851 - 1859
  • [50] Retinal Functional Changes Measured by Microperimetry in Neovascular Age-Related Macular Degeneration Treated With Ranibizumab
    Cho, Han Joo
    Kim, Chul Gu
    Yoo, Su Jin
    Cho, Sung Won
    Lee, Dong Won
    Kim, Jong Woo
    Lee, Joon H.
    [J]. AMERICAN JOURNAL OF OPHTHALMOLOGY, 2013, 155 (01) : 118 - 126